This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Women and HIV: Addressing Persistent Barriers to Prevention

Women and HIV: Addressing Persistent Barriers to Prevention

Format

Webcast

Time to Complete

1 hour

Released

November 15, 2019

Expires

November 14, 2020
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 Credit(s)TM
1.00 / Category 1 College Cognate Credit

Accredited Provider


American College of Obstetricians and Gynecologists (ACOG)

Commercial Supporter

This activity is supported by educational funding provided by Gilead Sciences, Inc.

Producer


Produced by Haymarket Medical Education (HME)

Program Description

The high HIV prevalence among men who have sex with men in the United States is well recognized; less so, however, is the impact of HIV on women. Nearly one-fifth of all new HIV infections in the US occur among women, with Black/African-American women disproportionately affected. Regionally, women of color who live in the southeastern United States have worse HIV-related health outcomes than do individuals who live in other parts of the country. In many ways, the US HIV epidemic among women has remained unappreciated and under-addressed, both among the populations at greatest risk and among the clinicians who care for them.

Recorded during the the Annual District Meeting of the American College of Obstetricians and Gynecologists (ACOG) Districts IV, VII, and XI on September 27, 2019, this program features ob-gyn Rachel Scott, MD, and infectious disease specialist David Wohl, MD, as they review evidence-based interventions for HIV prevention in women at risk. The expert faculty explore strategies for assessing risk in a non-biased manner, and provide guidance on how to utilize practical strategies for HIV prevention in routine clinical practice.

Intended Audience

Ob-gyns, women’s health nurse practitioners (NPs), and other clinicians who manage the care of patients with or at risk for HIV infection

Educational Objectives

At the conclusion of this activity, participants should be better able to:

  • Describe the current epidemiology of HIV infection among women in the United States
  • Utilize culturally competent, nonjudgmental gender- and sexuality-inclusive interviewing strategies to identify women at risk for HIV infection
  • Identify reasons for the underuse of HIV prevention strategies, including PrEP, among cis- and transgender women in the United States
  • Apply practical strategies to assess and address barriers to the provision of HIV prevention strategies in women at increased risk for infection

Conflict Of Interest Disclosure Policies

In accordance with the ACCME Standards for Commercial Support, HME requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational activities.

Faculty

Rachel K. Scott, MD, MPH, FACOG
Associate Vice Chair of Research, Women’s and Infants’ Services,
MedStar Washington Hospital Center Scientific Director of Women’s Health Research,
MedStar Health Research Institute
Assistant Professor, Georgetown University
Washington, DC

Dr. Scott receives clinical research support from Gilead Sciences, Inc.

David Alain Wohl, MD
Professor, Institute of Global Health and Infectious Diseases
The University of North Carolina at Chapel Hill
Site Leader, UNC Global HIV
Prevention and Treatment Research Site
Chapel Hill, NC

Dr. Wohl is a consultant to and is on the advisory boards of Gilead Sciences, Inc., Janssen Therapeutics, Merck, and ViiV Healthcare; and receives grant/research support from Gilead Sciences, Inc., Merck, and ViiV Healthcare.

Accredited Provider Disclosures

The American College of Obstetricians and Gynecologists staff involved in the planning and content review of this activity have no relevant financial relationships to disclose.

Reviewer Disclosures

Haymarket Medical Education staff and CME Peer Review involved in the planning and content review of this activity have no relevant financial relationships to disclose.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Obstetricians and Gynecologists and Haymarket Medical Education. The American College of Obstetricians and Gynecologists is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The American College of Obstetricians and Gynecologists designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 CreditTM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

College Cognate Credit(s)
The American College of Obstetricians and Gynecologists designates this enduring activity for a maximum of 1 Category I College Cognate Credit. The College has a reciprocity agreement with the AMA that allows AMA PRA Category 1 CreditTM  to be equivalent to College Cognate Credits.

Additional Credit Information

Physician Assistant Continuing Education
AAPA accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM   from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.00 Category 1 Credit for completing this activity.

Nurse Practitioner Continuing Education
AANPCP accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM   from organizations accredited by ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

Disclosure of Unlabeled Use

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.

Disclaimer

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the American College of Obstetricians and Gynecologists and Gilead Sciences, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Privacy Policy

Instructions

To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue